NM
Newtyn Management Portfolio holdings
AUM
$660M
This Quarter Return
+3%
1 Year Return
+22.08%
3 Year Return
+41.34%
5 Year Return
+148.8%
10 Year Return
+127.87%
AUM
$502M
AUM Growth
+$502M
(-1.4%)
Cap. Flow
-$31.2M
Cap. Flow
% of AUM
-6.22%
Top 10 Holdings %
Top 10 Hldgs %
68.95%
Holding
52
New
4
Increased
14
Reduced
13
Closed
12
Top Buys
| 1 |
Cogent Communications
CCOI
|
$24.5M |
| 2 |
Clearfield
CLFD
|
$12.3M |
| 3 |
IAC Inc
IAC
|
$11.3M |
| 4 |
AIV
Aimco
AIV
|
$10.7M |
| 5 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$10.1M |
Top Sells
| 1 |
Cannae Holdings
CNNE
|
$29.2M |
| 2 |
G-III Apparel Group
GIII
|
$25.8M |
| 3 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$15.3M |
| 4 |
Garrett Motion
GTX
|
$9.96M |
| 5 |
Ardagh Metal Packaging
AMBP
|
$9.47M |
Sector Composition
| 1 | Healthcare | 22.31% |
| 2 | Communication Services | 20% |
| 3 | Technology | 16.98% |
| 4 | Real Estate | 10.11% |
| 5 | Consumer Discretionary | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
89bio
ETNB
$1.37B
| $2.91M | 0.58% |
250,000
-22,500
| -8% | -$262K |
|
27
Mural Oncology
MURA
$35.9M
| $2.45M | 0.49% |
500,000
+55,000
| +12% | +$269K |
|
28
Bolt Biotherapeutics
BOLT
$9.29M
| $2.38M | 0.47% |
85,000
+7,323
| +9% | +$205K |
|
29
Adaptive Biotechnologies
ADPT
$1.96B
| $2M | 0.4% |
623,690
+301,690
| +94% | +$968K |
|
30
Phathom Pharmaceuticals
PHAT
$843M
| $1.75M | 0.35% |
165,000
-481,760
| -74% | -$5.12M |
|
31
Olema Pharmaceuticals
OLMA
$432M
| $1.7M | 0.34% |
150,000
| – | – |
|
32
Atea Pharmaceuticals
AVIR
$275M
| $1.62M | 0.32% |
400,000
-108,474
| -21% | -$438K |
|
|
TECX
33
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $1.43M | 0.29% |
93,241
-134,607
| -59% | -$2.07M |
|
34
Vanda Pharmaceuticals
VNDA
$279M
| $1.28M | 0.25% |
311,000
+21,000
| +7% | +$86.3K |
|
35
Aligos Therapeutics
ALGS
$75.1M
| $1.18M | 0.23% |
48,000
-2,200
| -4% | -$53.9K |
|
36
Sensei Biotherapeutics
SNSE
$10.9M
| $977K | 0.19% |
46,512
-32,089
| -41% | -$674K |
|
37
Adverum Biotechnologies
ADVM
$68.2M
| $653K | 0.13% |
46,189
-36,121
| -44% | -$511K |
|
38
Black Diamond Therapeutics
BDTX
$164M
| $634K | 0.13% |
125,000
-155,000
| -55% | -$786K |
|
|
LFLYW
39
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
| $19K | ﹤0.01% |
634,640
| – | – |
|
|
40
Ardagh Metal Packaging
AMBP
$2.1B
| – | – |
-2,464,881
| Closed | -$9.47M |
|
|
41
G-III Apparel Group
GIII
$1.17B
| – | – |
-760,207
| Closed | -$25.8M |
|
|
42
Garrett Motion
GTX
$2.61B
| – | – |
-1,029,523
| Closed | -$9.96M |
|
43
NB Bancorp
NBBK
$750M
| – | – |
-46,945
| Closed | -$631K |
|
44
Nukkleus
NUKK
$34.3M
| – | – |
-3,374
| Closed | -$76.9K |
|
45
Tilly's
TLYS
$61.2M
| – | – |
-62,784
| Closed | -$473K |
|
46
Q32 Bio
QTTB
$20.9M
| – | – |
-77,737
| Closed | -$851K |
|
|
ORKA
47
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
| – | – |
-22,443
| Closed | -$458K |
|
|
CYT
48
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| – | – |
-3,021,500
| Closed | -$9.19M |
|
|
ARIZR
49
DELISTED
Arisz Acquisition Corp. Right
ARIZR
| – | – |
-250,000
| Closed | -$52.5K |
|
|
MDRX
50
DELISTED
Veradigm Inc. Common Stock
MDRX
| – | – |
-1,461,692
| Closed | -$15.3M |
|